At the time of writing, eMagin Corporation (EMAN) stock had surged by 3.85% to the price of $2.7 in the premarket trading session. EMAN stock previously closed the session at $2.60 losing -1.14%. The EMAN stock volume traded at 0.45 million shares while the average trading volume for the past 3 months has been 2.01M. In the past year up-to-date EMAN shares have jumped up by 687.64%, and in the past week, the stock slumped by-16.40%. In the past three and six months, the stock has gained 0.39%, and 98.47% respectively. Furthermore, eMagin is currently valued in the market at $194.06 million and has 78.48 million outstanding shares.
What you need to know about eMagin Corporation
eMagin Corporation is a semiconductor equipment manufacturing company that specifically focuses on designing, developing, manufacturing, and commercializing of semiconductors’ light-emitting diodes like OLED displays. These OLED displays are projected on virtual imaging products and on-silicon micro displays. eMagin has its operations based in North America, Asia, and Europe. The company is headquartered in Hopewell Junction, New York.
eMagin Corp. also provides super video graphics array (SVGA) + OLED micro displays along with various other OLED graphics array like the ultra-widescreen display.
The company also provides design reference kits, for evaluation of microdisplay that are required by OEMs. The company’s clientele includes the military because they require aviation helmets, weapons sights and targeting systems, night vision and thermal imaging devices, ocular surgery visuals, mobile ultrasound, and augmented reality applications as well as training and simulations.
NordicNeuroLab is eying eMagin Corps.’ WUXGA product for its VisualSystem HD
eMagin Corp. has many major clients for which it produces its OLED and other light-emitting diodes. It continuously aims to increase its product portfolio and upgrade its operations to the newest generation of products for the semiconductor market demand. Most recently of the new products is the WUXGA which is designed for visual aid for near-to-eye applications. WUXGA provides high resolution and image quality with minimum power usage. It uses the proprietary thin-film OLED which allows the application in a wide arrange of products.
Recently NordicNeuroLab, a health/biotech equipment maker and specifically provider of fMRI equipment has taken an interest in the eMagin Corp.’s WUXGA. NordicNeuroLab wishes to partner with eMagin to incorporate WUXGA display in the VisualSystem HD for projecting high-resolution 2D and 3D images to patients during the fMRI.
This partnership can be based on long-term relationship and future collaboration between the two companies. Furthermore, getting NordicNeuroLab onboard as a client expands the share growth for EMAN stock in the medical fields for high-resolution and visual applications.
Receiving audit opinion of going concern qualification
eMagin on 13th April, the same day as the announcement of being selected bytNordicNeuroLab, had received an audit opinion for the going concern of qualification, which was required as per NYSE American’s listing requirements. EMAN stock had previously mentioned the qualification concern in the disclosing of its filed 10-K form for year ending 2020.